208 related articles for article (PubMed ID: 28337476)
21. Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.
Al Shweiki MR; Steinacker P; Oeckl P; Hengerer B; Danek A; Fassbender K; Diehl-Schmid J; Jahn H; Anderl-Straub S; Ludolph AC; Schönfeldt-Lecuona C; Otto M
J Psychiatr Res; 2019 Jun; 113():137-140. PubMed ID: 30953863
[TBL] [Abstract][Full Text] [Related]
22. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
[TBL] [Abstract][Full Text] [Related]
23. Individual Prediction of Behavioral Variant Frontotemporal Dementia Development Using Multivariate Pattern Analysis of Magnetic Resonance Imaging Data.
Zhutovsky P; Vijverberg EGB; Bruin WB; Thomas RM; Wattjes MP; Pijnenburg YAL; van Wingen GA; Dols A
J Alzheimers Dis; 2019; 68(3):1229-1241. PubMed ID: 30909224
[TBL] [Abstract][Full Text] [Related]
24. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders.
Katisko K; Cajanus A; Jääskeläinen O; Kontkanen A; Hartikainen P; Korhonen VE; Helisalmi S; Haapasalo A; Koivumaa-Honkanen H; Herukka SK; Remes AM; Solje E
J Neurol; 2020 Jan; 267(1):162-167. PubMed ID: 31595378
[TBL] [Abstract][Full Text] [Related]
25. Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort.
Krudop WA; Dols A; Kerssens CJ; Prins ND; Möller C; Schouws S; Barkhof F; van Berckel BN; Teunissen CE; van der Flier WM; Scheltens P; Sikkes SA; Stek ML; Pijnenburg YA
Dement Geriatr Cogn Disord; 2016; 41(1-2):16-26. PubMed ID: 26473985
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Accuracy of the Frontotemporal Dementia Consensus Criteria in the Late-Onset Frontal Lobe Syndrome.
Vijverberg EG; Dols A; Krudop WA; Peters A; Kerssens CJ; van Berckel BN; Wattjes MP; Barkhof F; Gossink F; Prins ND; Stek ML; Scheltens P; Pijnenburg YA
Dement Geriatr Cogn Disord; 2016; 41(3-4):210-9. PubMed ID: 27160162
[TBL] [Abstract][Full Text] [Related]
27. Increased Neurofilament Light Chain and YKL-40 CSF Levels in One Japanese IBMPFD Patient With VCP R155C Mutation: A Clinical Case Report With CSF Biomarker Analyses.
Ikeda M; Kuwabara T; Takai E; Kasahara H; Furuta M; Sekine A; Makioka K; Yamazaki T; Fujita Y; Nagashima K; Higuchi T; Tsushima Y; Ikeda Y
Front Neurol; 2020; 11():757. PubMed ID: 32849216
[TBL] [Abstract][Full Text] [Related]
28. Identifying bvFTD Within the Wide Spectrum of Late Onset Frontal Lobe Syndrome: A Clinical Approach.
Krudop WA; Kerssens CJ; Dols A; Prins ND; Möller C; Schouws S; van der Flier WM; Scheltens P; Sikkes S; Stek ML; Pijnenburg YA
Am J Geriatr Psychiatry; 2015 Oct; 23(10):1056-66. PubMed ID: 25921226
[TBL] [Abstract][Full Text] [Related]
29. Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia.
Constantinides VC; Boufidou F; Bourbouli M; Pyrgelis ES; Ghika A; Koros C; Liakakis G; Papageorgiou S; Stefanis L; Paraskevas GP; Kapaki E
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766437
[TBL] [Abstract][Full Text] [Related]
30. A phase 1b open-label study of sodium selenate as a disease-modifying treatment for possible behavioral variant frontotemporal dementia.
Vivash L; Malpas CB; Meletis C; Gollant M; Eratne D; Li QX; McDonald S; O'Brien WT; Brodtmann A; Darby D; Kyndt C; Walterfang M; Hovens CM; Velakoulis D; O'Brien TJ
Alzheimers Dement (N Y); 2022; 8(1):e12299. PubMed ID: 35574563
[TBL] [Abstract][Full Text] [Related]
31. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
[TBL] [Abstract][Full Text] [Related]
32. Formal Psychiatric Disorders are not Overrepresented in Behavioral Variant Frontotemporal Dementia.
Gossink FT; Dols A; Krudop WA; Sikkes SA; Kerssens CJ; Prins ND; Scheltens P; Stek ML; Pijnenburg YA
J Alzheimers Dis; 2016; 51(4):1249-56. PubMed ID: 26967225
[TBL] [Abstract][Full Text] [Related]
33. The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.
Krudop WA; Dols A; Kerssens CJ; Eikelenboom P; Prins ND; Möller C; Schouws S; Rhebergen D; van Exel E; van der Flier WM; Sikkes S; Scheltens P; Stek ML; Pijnenburg YAL
J Alzheimers Dis; 2017; 60(3):959-975. PubMed ID: 28984605
[TBL] [Abstract][Full Text] [Related]
34. The Value of Neuropsychological Assessment in the Differentiation Between Behavioral Variant Frontotemporal Dementia and Late-Onset Psychiatric Disorders.
Overbeek JM; Korten N; Gossink F; Fieldhouse J; van de Beek M; Reus L; Dols A; Pijnenburg Y; Schouws S
J Clin Psychiatry; 2020 Feb; 81(1):. PubMed ID: 32023367
[TBL] [Abstract][Full Text] [Related]
35. Perivascular spaces as a marker of disease severity and neurodegeneration in patients with behavioral variant frontotemporal dementia.
Moses J; Sinclair B; Schwartz DL; Silbert LC; O'Brien TJ; Law M; Vivash L
Front Neurosci; 2022; 16():1003522. PubMed ID: 36340772
[TBL] [Abstract][Full Text] [Related]
36. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
Engelborghs S
Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
[TBL] [Abstract][Full Text] [Related]
37. CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
Körtvelyessy P; Heinze HJ; Prudlo J; Bittner D
Front Neurol; 2018; 9():504. PubMed ID: 30013506
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Cerebrospinal Fluid Neurofilament Light Chain as a Routine Biomarker in a Memory Clinic.
Niikado M; Chrem-Méndez P; Itzcovich T; Barbieri-Kennedy M; Calandri I; Martinetto H; Serra M; Calvar J; Campos J; Russo MJ; Pertierra L; Allegri R; Sevlever G; Surace EI
J Gerontol A Biol Sci Med Sci; 2019 Mar; 74(4):442-445. PubMed ID: 30107413
[TBL] [Abstract][Full Text] [Related]
39. No added diagnostic value of non-phosphorylated tau fraction (p-tau
Goossens J; Bjerke M; Struyfs H; Niemantsverdriet E; Somers C; Van den Bossche T; Van Mossevelde S; De Vil B; Sieben A; Martin JJ; Cras P; Goeman J; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
Alzheimers Res Ther; 2017 Jul; 9(1):49. PubMed ID: 28709448
[TBL] [Abstract][Full Text] [Related]
40. The Frontotemporal Dementia versus Primary Psychiatric Disorder (FTD versus PPD) Checklist: A Bedside Clinical Tool to Identify Behavioral Variant FTD in Patients with Late-Onset Behavioral Changes.
Ducharme S; Pearl-Dowler L; Gossink F; McCarthy J; Lai J; Dickerson BC; Chertkow H; Rapin L; Vijverberg E; Krudop W; Dols A; Pijnenburg Y
J Alzheimers Dis; 2019; 67(1):113-124. PubMed ID: 30584146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
